Impax Laboratories Inc. could borrow up to $50 million from Wells Fargo Bank under a new revolving credit facility.
The line of credit can be used for working capital, general corporate and other purposes, the Hayward-based maker of generic drugs (NASDAQ: IPXL) said Thursday in a Securities and Exchange Commission filing. Up to $10 million of the facility can be used for letters of credit, the company said.
No comments:
Post a Comment